A ‘perfect storm’ of spiraling oncology drug costs will require pragmatic and perhaps radical changes to pharmaceutical reimbursement systems such as the PBS, an Australian forum has been told. Experts have warned that oncologists may be unable to access the many high cost treatments coming out of drug company pipelines unless there are changes to ...
Can oncology weather the ‘perfect storm’ of drug cost blowouts?
By Michael Woodhead
20 Nov 2019